Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 1-7 , February 2009

The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2008

  • John G.T. Augoustides, MD, FASE

      Affiliations

    • Corresponding Author InformationAddress reprint requests to John G.T. Augoustides, MD, FASE, Department of Anesthesiology and Critical Care, Cardiothoracic and Vascular Section, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104-4283

References 

  1. Mangano DT, Tudor JC, Dietzel C Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353–365
  2. Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801–2813
  3. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007;4:CD001886
  4. Fergusson D, Glass KC, Hutton B, et al. Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?. Clin Trials. 2005;2:218–230
  5. Augoustides JG, Fleisher LA. Comment on: Fergusson D, Glass KC, Hutton B, Shapiro S (Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?). Clin Trials. 2005;2:231–232
  6. Fergusson DA, Hebert PC, Mazer CD, et al. BART Investigators A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–2331
  7. Ray WA, Stein CM. The aprotinin story—Is BART the final chapter?. N Engl J Med. 2008;358:2398–2400
  8. Augoustides JG. Perioperative safety of aprotinin in coronary artery bypass graft surgery: Is there life after BART?. Drug Saf. 2008;31:557–560
  9. Kluth M, Lueth JU, Zittermann A, et al. Safety of low-dose aprotinin in coronary artery bypass graft surgery: A single-centre investigation in 2, 436 patients in Germany. Drug Saf. 2008;31:617–626
  10. Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358:784–793
  11. Schneeweiss S, Seeger JD, Landon J, et al. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358:771–783
  12. Ferguson TB. Aprotinin—Are there lessons learned?. JAMA. 2007;297:527–529
  13. Ray WA. Learning from aprotinin-mandatory trials of comparative efficacy and safety needed. N Engl J Med. 2008;358:840–842
  14. Sundt TM. The demise of aprotinin: Our share of the blame. J Thorac Cardiovasc Surg. 2008;135:729–731
  15. Myles PS. Aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;359:1181
  16. Myles PS, Smith J, Knight J, et al. Aspirin and tranexamic acid for coronary artery surgery (ATACAS) trial: rationale and design. Am Heart J. 2008;155:224–230
  17. Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2008;June 4 [Epub ahead of print]
  18. Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute postoperative hypertension in cardiac surgery patients: An efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized double-blind, placebo-controlled trial. Anesth Analg. 2008;107:59–67
  19. Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110–1121
  20. Walsh SR, Tang TY, Kullar P, et al. Ischaemic preconditioning during cardiac surgery: Systematic review and meta-analysis of perioperative outcomes in randomized clinical trials. Eur J Cardiothorac Surg. 2008;Sep 8 [Epub ahead of print]
  21. Wang L, Ola N, Tropak M, et al. Remote ischemic preconditioning elaborates a blood-borne mediator that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest. J Thorac Cardiovasc Surg. 2008;136:335–342
  22. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473–481
  23. Cavolli R, Kaya K, Aslan A, et al. Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization: A pilot study?. Circulation. 2008;118:476–481
  24. Meyer K, Schipke JD, Klocke RC, et al. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart. Thorac Cardiovasc Surg. 2008;56:379–385
  25. Osthaus WA, Boethig D, Winterhalter M, et al. First experience with intraoperative levosimendan in pediatric cardiac surgery. Eur J Pediatr. 2008;Sep 24 [Epub ahead of print]
  26. Koch CG, Liang L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–1239
  27. Benjamin RJ, Dodd RV. Red-cell storage and complications of cardiac surgery. N Engl J Med. 2008;358:2840–2841
  28. Hall SW. Red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:2841
  29. Frenzel T, Sibrowski W, Westphal M. Red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:2841
  30. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208
  31. Karkouti K, Wileysundera DN, Yau TM, et al. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion. 2008;48:666–672
  32. Descoutures F, Himbert D, Lepage L, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J. 2008;29:1410–1417
  33. Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation—Proof of concept. Eur J Cardiothorac Surg. 2007;31:9–15
  34. Lozonschi L, Quaden R, Edwards NM, et al. Transapical mitral valve stent implantation. Ann Thorac Surg. 2008;86:745–748
  35. Kempfert J, Blumenstein JM, Borger MA, et al. Minimally invasive off-pump valve-in-a-valve implantation: The atrial transcatheter approach for re-operative mitral valve replacement. Eur Heart J. 2008;29:2382–2387
  36. Walther T, Kempfert J, Borger MA, et al. Human minimally invasive off-pump valve-in-a-valve implantation. Ann Thorac Surg. 2008;85:1072–1073
  37. Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: First report in a human patient. Catheter Cardiovasc Interv. 2006;67:659–662
  38. Orniston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet. 2008;371:899–907
  39. Windecker S, Serruys PW, Wandel S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (Leaders): A randomized, non-inferiority trial. Lancet. 2008;372:1163–1173
  40. Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin “resistance” and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ. 2008;336:195–198
  41. Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008;29:992–1000
  42. Gori AM, Marcucci R, Migliorini A, et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol. 2008;52:734–739

PII: S1053-0770(08)00349-2

doi: 10.1053/j.jvca.2008.11.003

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 1-7 , February 2009

Article Tools